目次

TABLE OF CONTENTS

1 INTRODUCTION?
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY?
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.2 MARKET ESTIMATION METHODOLOGY
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
2.4 INSIGHTS FROM PRIMARIES
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY?

4 PREMIUM INSIGHTS?

5 MARKET OVERVIEW?
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.5 SUPPLY/VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM/MARKET MAP
5.7 PORTERS FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITION RIVALRY
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY PRODUCT
5.8.2 AVERAGE SELLING PRICE TREND
5.9 PATENT ANALYSIS?
5.10 TECHNOLOGY ANALYSIS?
5.11 REGULATORY ANALYSIS?
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 KEY CONFERENCES & EVENTS IN 2022-2023
5.13 KEY STAKEHOLDERS & BUYING CRITERIA

6 RECOMBINANT PROTEINS MARKET, BY PRODUCT?
6.1 INTRODUCTION
6.2 GROWTH FACTORS AND CHEMOKINES
6.3 STRUCTURAL PROTEINS
6.4 KINASE PROTEINS
6.5 REGULATORY PROTEINS
6.6 MEMBRANE PROTEINS
6.7 RECOMBINANT METABOLIC ENZYMES?
6.8 ADHESION MOLECULES AND RECEPTORS
6.9 IMMUNE RESPONSE PROTEINS
6.10 OTHER RECOMBINANT PROTIENS (VIRAL ANTIGENS)

7 RECOMBINANT PROTEINS MARKET, BY APPLICATION?
7.1 INTRODUCTION
7.2 DRUG DISCOVERY AND DEVELOPMENT
7.2.1 BIOLOGICS
7.2.2 VACCINE
7.2.3 C&G THERAPY
7.3 BIOPHARMACEUTICAL PRODUCTION
7.4 BIOTECHNOLOGY RESEARCH
7.5 ACADEMIC RESEARCH INSTITUTE
7.6 DIAGNOSTICS
7.7 OTHER APPLICATIONS

8 RECOMBINANT PROTEIN MARKET, BY END USER?
8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
8.3 BIOTECHNOLOGY COMPANIES
8.4 ACADEMIC RESEARCH INSTITUTES
8.5 CONTRACT RESEARCH ORGANIZATIONS
8.6 OTHER END USERS

9 RECOMBINANT PROTEINS MARKET, BY REGION?
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.3 ITALY
9.3.4 SPAIN
9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA?
9.6 MIDDLE EAST AND AFRICA

10 COMPETITIVE LANDSCAPE?
10.1 OVERVIEW
10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2020/2021)
10.3 MARKET SHARE ANALYSIS (2021)
10.4 COMPANY EVALUATION QUADRANT
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
10.4.5 COMPETITIVE BENCHMARKING
10.5 START-UP/SME EVALUATION QUADRANT
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES
10.6 COMPETITIVE BENCHMARKING?
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES
10.7.2 DEALS
10.7.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES?

* Company profiles of 25 players (Including MNC and local players) will be provided in this section. This section will include Business Overview, Products Offered, Recent Developments, MnM View. Kindly note that, the financial analysis might not be captured in case of unlisted companies

12 APPENDIX?
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS